ArticleJournal of translational medicine2010

In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor.

Ursula Kurzik-Dumke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.